Obesity: open trials in Spain

109 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT07595549
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Trial Treatment · Phase 3 · Pfizer
Instituto Medico Quirurgico San Rafael S.A., A Coruna · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-05
NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Trial Treatment · Phase 3 · Eli Lilly and Company
C.R.A. Investigación Clínica, A coruña · Accellacare Espana S.L., Alcobendas · Equip D'atencio Primaria Barcelona Sardenya S.L.P., Barcelona · FutureMeds Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · EAP Osona Sud - Alt Congost S.L.P, Centelles · Futuremeds Spain S.L., Chiclana De La Frontera · Hospital Vithas La Salud, Granada · Futuremeds Spain S.L., Madrid · Centro de Salud San Juan de la Cruz, Madrid · Vithas Hospital Sevilla, Sevilla · Futuremeds Spain S.L., Sevilla · Hospital Ascires, Valencia
Registry updated 2026-11-05
NCT07919405
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Trial Treatment · Phase 3 · Novo Nordisk A/S
Hospital Universitario de Badajoz, Badajoz · Centro Médico Quirón-Teknon, Barcelona · Clinic Barcelona_Endocrinología, Barcelona · H. de León_Endocrinología, León · H.G.Marañón_Endocrino-Obesidad, Madrid · Hospital Universitario Sanitas Virgen del Mar, Madrid · H. Univ. Marqués de Valdecilla_Endocrinología, Santander · Clínica Gaias - Santiago, Santiago de Compostela
Registry updated 2026-11-05
NCT06672549
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Regional Universitario de Malaga - Hospital Materno-Infantil, Málaga · Corporacio Sanitaria Parc Tauli, Sabadell · Instituto Hispalense de Pediatria, Seville · Hospital Universitario de Araba (HUA)- Hospital Txagorritxu, Vitoria-Gasteiz
Registry updated 2026-11-04
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitari Vall d'Hebron, Barcelona · Centro Médico Teknon, Barcelona · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Arquitecto Marcide, Ferrol · Hospital de Cabuenes, Gijón · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Central De Asturias, Oviedo · Complejo Hospitalario de Navarra, Pamplona · Hospital Universitario Virgen Macarena, Seville · Hospital Universitari i Politécnic La Fe, Valencia
Registry updated 2026-11-04
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Centro Médico Teknon, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Arquitecto Marcide, Ferrol · Hospital de Cabuenes, Gijón · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Central De Asturias, Oviedo · Complejo Hospitalario de Navarra, Pamplona · Hospital Universitario Virgen Macarena, Seville · Hospital Universitari i Politécnic La Fe, Valencia
Registry updated 2026-11-04
NCT07062094
Safety and Effectiveness of Orbera365™ Intragastric Balloon System
Research · Boston Scientific Corporation
EndoBes - Centre Medico Teknon, Barcelona · Dorsia Clinic, Madrid Spain, Madrid
Registry updated 2026-11-04
NCT07282600
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario de La Ribera, Alzira · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Hospital Ruber Juan Bravo, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Regional de Málaga, Málaga · University Hospital Virgen Del Rocio S.L., Sevilla · Centro Médico Compostela
Registry updated 2026-11-04
NCT07369011
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario de Guadalajara, Guadalajara · Hospital Universitari de Santa Maria, Lleida · Hospital San Pedro, Logroño · Instituto de Investigaciones del Sueno, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Quiron Infanta Luisa, Seville · Hospital Universitario Virgen del Rocio, Seville
Registry updated 2026-11-04
NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Trial Treatment · Phase 3 · Eli Lilly and Company
Instituto Medico Quirurgico San Rafael S.A., A Coruna · Hospital Universitario Torrecárdenas, Almería · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Instituto Gallego de Cirugía Ocular, Ferrol · Clinica Juaneda S.A., Palma · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Quironsalud Infanta Luisa, Sevilla · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla
Registry updated 2026-11-04
NCT07817875
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Regional Universitario de Malaga - Hospital Materno-Infantil, Málaga · Corporacio Sanitaria Parc Tauli, Sabadell · Instituto Hispalense de Pediatria, Seville · Hospital Universitario de Araba (HUA)- Hospital Txagorritxu, Vitoria-Gasteiz
Registry updated 2026-11-04
NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
CHUAC-Complejo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario de La Ribera, Alzira · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Naval, Ferrol · Hospital Vithas La Salud, Granada · H.R.U Málaga - Hospital Civil, Málaga · Hospital Universitario Virgen del Rocio, Seville · Vithas Hospital Sevilla, Seville
Registry updated 2026-11-04
NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Trial Treatment · Phase 3 · Eli Lilly and Company
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario de La Ribera, Alzira · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Area Sanitaria De Ferrol, Ferrol · Hospital Vithas La Salud, Granada · Hospital Polusa S.A., Lugo · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · University Hospital Son Espases, Palma · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-03
2025-522699-94-00
Maridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
Trial Treatment · Phase 3 · Amgen Inc.
Instituto Medico Quirurgico San Rafael S.A., A Coruna · Hospital Universitari Vall d'Hebron, Barcelona · Centro Medico Teknon - Grupo Quironsalud, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Registry updated 2026-11-02
NCT07908940
Changes in Body Composition Following Pharmacological Treatment for Obesity.
Research · Hospital San Carlos, Madrid
Hospital Clínico San Carlos, Madrid
Registry updated 2026-11-02
NCT07850063
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
Hospital Universitario Virgen de la Arrixaca, El Palmar · Hospital Virgen del Camino, Sanlúcar de Barrameda · Ascires, Valencia
Registry updated 2026-10-30
NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Trial Treatment · Phase 3 · Amgen
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clínic i Provincial de Barcelona, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Marina Salud de Denia, Denia · Hospital Universitario Virgen de la Arrixaca, El Palmar · Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria · Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat · Hospital Universitario Arnau de Vilanova - Lleida, Lleida · Hospital Clínico San Carlos, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda · Hospital Clinico Universitario Virgen de La Victoria, Málaga · Hospital Universitario De Salamanca, Salamanca · Hospital General Universitario Valencia, Valencia · Hospital Universitari i Politécnic La Fe, Valencia · Hospital Clinico Universitario de Valencia, Valencia · Hospital Vithas Valencia Turia, Valencia
Registry updated 2026-10-29
NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Trial Treatment · Phase 3 · AstraZeneca
A Coruña · Alzira (Valencia) · Barcelona · Castilleja de La Cuesta, Sevilla · Ferrol (A Coruña) · Lleida · Málaga · Oviedo · Segovia · Seville
Registry updated 2026-10-28
2024-516654-22-00
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Trial Treatment · Phase 3 · Amgen Inc.
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital De Denia, Denia · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · Hospital Universitario 12 de Octubre, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Virgen de la Victoria, Málaga · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Universitario De Salamanca, Salamanca · Hospital Vithas Valencia Turia S.L., Valencia · Hospital Clinico Universitario de Valencia, Valencia · Consorcio Hospital General Universitario de Valencia, Valencia · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-27
NCT07896265
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Hospital Universitario de Badajoz, Badajoz · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario De Leon, León · Hospital Universitario Regional de Málaga, Málaga · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Virgen del Camino, Sanlúcar de Barrameda · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla · Hospital Virgen de las Montañas, Villamartín
Registry updated 2026-10-26
NCT07220772
A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat
Registry updated 2026-10-22
NCT06828367
EFFECT OF A ONLINE NUTRITION EDUCATION PROGRAM IN PRESCHOOLER'S FAMILIES ON THEIR ADHERENCE TO THE MEDITERRANEAN DIET
Trial Treatment · Fundacion Miguel Servet
Asociación Navarra de Pediatría, Pamplona
Registry updated 2026-10-16
NCT06987903
Impact of a Perioperative Physical Exercise and Respiratory Physiotherapy Program on the Patient Undergoing Bariatric Surgery
Trial Treatment · Fundacin Biomedica Galicia Sur
Hospital Alvaro Cunqueiro, Vigo
Registry updated 2026-10-13
NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Instituto Medico Quirurgico San Rafael S.A., A Coruna · Hospital del Mar, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Hospital Clínico San Carlos, Madrid · Hospital Ruber Juan Bravo, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Quironsalud Infanta Luisa, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-13
NCT07351058
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Germans Trias i Pujol, Badalona · Centro Medico Teknon - Grupo Quironsalud, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Area Sanitaria De Ferrol, Ferrol · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla
Registry updated 2026-10-13

All Obesity trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error